Areas of Focus
- 前列腺癌发生发展及侵袭转移分子机制
- 肿瘤代谢与微环境
Work Experience
- 2002.7-2015.8 助教、讲师: 重庆医科大学检验系实验诊断教研室
- 2007.7-2007.8 进修: 重庆医科大学第一附属医院检验科
- 2015.9-至今 副教授: 重庆医科大学检验医学院实验诊断教研室
Academic Background & Achievements
- 1997.9-2002.6 儿科医学: 重庆医科大学
- 2004.9-2007.7 临床检验诊断学硕士: 重庆医科大学
- 2011.9-2015.7 组织工程与细胞工程博士: 重庆医科大学
- 2019.5-2020.5 访问学者: 加拿大多伦多大学圣迈克尔医院
Publications
- HepaCAM-PIK3CA axis regulates the reprogramming of glutamine metabolism to inhibit prostate cancer cell proliferation, ZHENGTING HE, YINGYING GAO, TING LI, CHAOWEN YU, LIPING OU*, CHUNLI LUO*, 2022
- PLCε knockdown inhibits prostate cancer cell proliferation via suppression of Notch signalling and nuclear translocation of the androgen receptor, Yin Wang, Xiaohou Wu, Liping Ou, Xue Yang, Xiaorong Wang, Min Tang, E. Chen, Chunli Luo, 2015
- HepaCAM Regulates Warburg Effect of Renal Cell Carcinoma via HIF-1a/ NF-kB Signaling Pathway, Yanru Fan, Liping Ou, Jiaxin Fan, Luo Li, Xiaohou Wu, Chunli Luo, M.D., Yingying Gao, and Lingfang Niu, 2019
- The Wnt antagonist Dkk1 regulates differentiation of mouse embryonic stem cells in vitro and in vivo, LIPING OU, LIAOQIONG FANG, HEJING TANG, HAI QIAO, XIAOMEI ZHANG and ZHIBIAO WANG, 2016
- Knockdown of PLCε inhibits inflammatory cytokine release via STAT3 phosphorylation in human bladder cancer cells, Xue Yang#, Liping Ou#, Min Tang, Yin Wang, Xiaorong Wang, E Chen, Jianjun Diao, Xiaohou Wu, Chunli Luo*, 2015